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Endovascular chimney technique versus open
repair of juxtarenal and suprarenal aneurysms
Kevin J. Bruen, MD,a Robert J. Feezor, MD,a Michael J. Daniels, PhD,b Adam W. Beck, MD,a
and W. Anthony Lee, MD,c Gainesville and Boca Raton, Fla
Objective: To compare early outcomes of endovascular repair of juxtarenal and suprarenal aneurysms using the chimney
technique with open repair in anatomically-matched patients.
Methods: Between January 2008 and December 2009, 21 patients underwent endovascular repair of juxtarenal and
suprarenal aortic aneurysms with chimney stenting (Ch-EVAR) of 1 or 2 renal and/or superior mesenteric artery (SMA)
vessels. These were compared with 21 anatomically-matched patients that underwent open repair (OR) during the same
time period. Primary end points were 30-day mortality, chimney stent patency, and type Ia endoleak. Secondary end
points included early complications, renal function, blood loss, and length of stay (LOS).
Results: Despite a higher proportion of women, oxygen-dependent pulmonary disease and lower baseline renal function,
30-day mortality was identical with one death (4.8%) in each group. Blood loss and total LOS were significantly less for
Ch-EVAR. Six patients (29%) in the chimney group had acute kidney injury (AKI) compared with the open group, in
which there were one (4.8%) AKI and four (19%) acute renal failures, of which two (9.5%) required chronic hemodialysis.
Renal function at 12 months demonstrated similar declines in the overall estimated glomerular filtration rate (eGFR) in
the Ch-EVAR and OR groups (11.1  19.6 vs 10.4  25.2, P  NS, respectively). There was one asymptomatic SMA
stent occlusion at 6 months and partial compression of a second SMA stent which underwent repeat balloon angioplasty.
Primary patency at 6 and 12 months was 94% and 84%, respectively. There was one type Ia endoleak noted at 30 days
which resolved by 6 months.
Conclusions:Ch-EVARmay extend the anatomical eligibility of endovascular aneurysm repair using conventional devices.
It appears to have similar mortality to open repair with less morbidity. Long-term durability and stent patency remain to
be determined. (J Vasc Surg 2011;53:895-905.)
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EThe proximal landing zone is one of the limiting factors
for endovascular aneurysm repair (EVAR) and represents
the single most important factor for success or failure of the
therapy. It is estimated that 30% to 40% of patients are not
eligible for EVAR using currently available conventional
devices.1 Alternative treatment options include open re-
pair, hybrid debranching procedures,2-4 and fenestrat-
ed5-11 and branched endografts12-18 that are not currently
readily available.
Despite relatively low perioperative mortality rates of
some single center experiences,19,20 a recent study showed
the 1-year mortality of patients over the age of 70 with
chronic obstructive pulmonary disease (COPD) who un-
dergo a suprarenal cross-clamp to be almost 30%.21 The
perioperative complications of aortic aneurysm repair in-
cluding myocardial infarction, pneumonia, and impaired
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doi:10.1016/j.jvs.2010.10.068enal function are well recognized. Long-term complica-
ions of open repair include graft complications in 10% to
5% of patients, small bowel obstruction, and abdominal
all hernias.22
The chimney technique was originally described by
reenberg23 as an adjunctive procedure involving branch
essel stenting during intentional endograft coverage of the
essel origin to maintain branch perfusion. It may be used
n anatomically unfavorable proximal landing zones, such
s short or severely angulated necks, when alternative tech-
iques and/or devices are not options.
The current literature on this technique is limited to
mall series citing early technical success and out-
omes.24-30 A study comparing clinical outcomes to open
epair has not yet been reported. The purpose of our study
s to compare the early outcomes of endovascular repair of
uxtarenal and suprarenal aneurysms using the chimney
echnique with open repair in anatomically-matched pa-
ients.
ETHODS
Treatment algorithm for juxtarenal and suprarenal
ortic aneurysms. The algorithm for managing juxtarenal
nd suprarenal aneurysms during the study period is shown
n Fig 1. Patients who were deemed physiologically fit
nderwent conventional open repair. Higher-risk patients
ith juxtarenal or suprarenal aortic aneurysms 5.5 cm,
ersistent proximal type I endoleaks after conventional
VAR, proximal para-anastomotic pseudoaneurysms after
pen infrarenal repair, or infrarenal aneurysms with short,
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April 2011896 Bruen et alconical, and/or severely angulated proximal necks were
considered for endovascular chimney repair (Ch-EVAR).
Case planning was performed using computed tomo-
graphic angiogram (CTA) datasets reconstructed on a
three-dimensional (3D) workstation (iNtuition; Tera-
Recon, San Mateo, Calif).
Case planning for a Ch-EVAR procedure was predi-
cated on how much proximally on the abdominal aorta to
land the endograft. The optimal landing zone required at
least 20-mm of good quality, relatively straight aorta prox-
imal to the aneurysm. For most commercially available
abdominal endografts, the instructions for use (IFU) for
proximal neck length is 15 mm. An additional 5 mm was
arbitrarily chosen to provide extra length to minimize the
chance of endoleak. After this segment was identified,
which and howmany of the branch vessels will be chimney-
stented was decided. If the proximal margin of this 20-mm
landing zone required total or near total coverage of a
branch vessel, the intended landing zone was moved supe-
riorly to the inferior margin of the next most proximal
branch vessel. Therefore, for a single renal chimney, the
new proximal landing zone was moved to the base of the
contralateral (superior) renal artery, for two renal chimneys
it was moved to the SMA, and so forth.
Functional renal tests were not performed preopera-
tively. In general, if there was a disparity of kidney paren-
chyma on the computed tomography (CT) (size and cor-
tical thickness), the larger kidney was preserved. When the
two kidneys appeared equivalent, the right kidney or a
more favorable renal artery anatomy (down-going angle,
larger diameter, less occlusive disease, no early branching,
etc) was preserved.
The maximum number of vessels that can be safely
chimney-stented has never been systematically studied and
remains unknown. Based on prior reported experiences by
others,26 we arbitrarily elected to limit this number to two
chimneys. Therefore, for suprarenal aneurysms whose
proximal landing zone extended to the base of the celiac
artery, the SMA and one renal artery were chimney stented
Fig 1. Clinical decision algorithm for juxtarenal and sup
SMA, superior mesenteric artery.with intentional coverage of the other renal artery (Fig 2). tf the intentionally covered renal artery arose from the
ortic aneurysm itself, then embolization was considered to
void a type II endoleak. The main body aortic stent graft
Zenith Flex; Cook, Inc, Bloomington, Ind) was oversized
0% to 15% per manufacturer’s IFU relative to the outer
iameter of the proximal landing zone. Thoracic en-
ografts were used in the suprarenal position when the
ortic diameter was larger then the largest abdominal de-
ice available.
Chimney-EVAR technique. The chimney technique
as been previously described.23,26,27,29 The majority of
atients underwent repair with general anesthesia. Bilateral
emoral accesses and axillary or brachial access were ob-
al aneurysms. Ch-EVAR, Endovascular chimney repair;
ig 2. Volume-rendered 3D reconstruction of the endograft at
he base of the celiac artery with chimney stenting of the superior
esenteric artery (SMA) and right renal artery. The left renal artery
as intentionally covered.rarenained in the usual manner, and guidewires placed in the
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Volume 53, Number 4 Bruen et al 897aorta. The intended branch vessel(s) was (were) selectively
catheterized and 7F or 8F 90-cm sheath(s) was (were)
advanced over Rosen guidewire(s) (Cook, Inc, Blooming-
ton, Ind) and deeply intubated into the target branch
vessel(s). The patient was heparinized to maintain an acti-
vated clotting time of 200 to 250 s. The endograft main
body was next deployed below the proximal target vessel
(superior renal, SMA, or celiac artery). The endograft main
body stabilized the long branch vessel sheaths for introduc-
tion of the chimney stents. The chimney stent(s) (iCast;
Atrium, Hudson, NH) was (were) inserted into the trans-
brachial (axillary) sheath(s) and positioned at least 20 mm
into the branch vessel(s) and the superior edge of the
stent(s) was (were) positioned 5 to 10 mm above the
covered portion of the main body. The sheath(s) was
(were) pulled back and the chimney stent(s) deployed. The
contralateral gate was cannulated and the limb deployed in
the usual manner. As a final step, simultaneous “kissing”
balloon molding was performed using a compliant aortic
balloon in the endograft and reinflation of the balloons for
the iCast stents (Fig 3). Completion angiography was
performed and any proximal endoleaks were simply re-
ballooned. No additional cuff placements or Palmaz stents
Fig 3. Triple “kissing-balloon” molding of the endograft and
two renal chimney stents.were utilized. The case was completed in a routine manner. CPatients were started on clopidogrel starting on the
ight of surgery. Serum creatinine levels were obtained
aily while the patient was in the hospital. Follow-up
ncluded a clinic visit with a serum creatinine level and a
TA of the abdomen and pelvis at 1 month and every 6
onths. In patients with a diminished renal function, a
oncontrast CT scan and a color-flow duplex ultrasound
ere used to assess the stent graft, aneurysm size, endoleak,
nd chimney stent patency.
Retrospective anatomically-matched cohort. Twenty-
ne EVAR with chimney stenting of juxtarenal and su-
rarenal aneurysms were performed between January 2008
nd December 2009. These were compared with an
natomically-matched cohort selected in a consecutive re-
erse chronologic order that underwent OR during the
ame time period. A total of 39 patients required review to
dentify a cohort of 21 open patients who potentially could
ave undergone a Ch-EVAR using the same decision lad-
er illustrated in Fig 1. The potential endovascular repairs
nd the actual aortic clamp placements of the 21 open
epairs and the reasons for exclusion of the remaining 18
atients are listed in Fig 4.
Outcome measures included 30-day mortality, renal
unction, incidence of proximal type I endoleak, and pri-
ary chimney stent patency. Complications were scored
sing a composite morbidity index.31 Other perioperative
easures such as blood loss, transfusion requirements,
ospital LOS, and postdischarge disposition were exam-
ned.
Estimated glomerular filtration rate (eGFR) was calcu-
ated using the Chronic Kidney Disease Epidemiology Col-
aboration (CKD-EPI) formula which better estimates
FR above 60 mL/min/1.73 m2 than other formulas.32
cute kidney injury (AKI) and acute renal failure (ARF)
ere based on the RIFLE (Risk, Injury, Failure, Loss and
nd-stage kidney disease) criteria.33 AKI was defined as a
oubling of creatinine or50% decline in eGFR. ARF was
efined as a threefold increase in creatinine, a75% decline
n renal function, or a serum creatinine of4 mg/dL with
n acute rise of 0.5 mg/dL. Early changes in renal function
ere calculated by comparing the baseline laboratory value
o that obtained on postoperative day 10 or the last avail-
ble value if the patient was discharged earlier. Midterm
enal function was determined by comparing the baseline
alue and the most recent available laboratory value.
Differences in renal function were calculated using the
onparametric Kruskal-Wallis and exact Wilcoxon scores
ests. Continuous variables were compared using a Student
test and Wilcoxon Mann-Whitney test, and categorical
ariables compared with Fisher’s exact test.
ESULTS
Demographic and anatomical data are shown in Table
. The mean ages in the two groups were similar. There
ere a higher proportion of women, oxygen-dependent
OPD, and chronic renal insufficiency (creatinine 1.8
g/dL) in the Ch-EVAR group. Baseline eGFR of the
h-EVAR group was lower compared with the OR group
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April 2011898 Bruen et al(60.5  34.5 vs 72.9  17.4 mL/min/1.73 m2). The
mean aneurysm size in the Ch-EVAR group was larger
(66.8  12.7 mm vs 60.5  9.9 mm). The dimensions of
the infrarenal proximal landing zone were similar in both
groups, with a resultant (potential) increase in neck length
of 20mmusing the chimney technique (for theOR group).
Indications, device characteristics, and adjunctive pro-
cedures are listed in Table II. Twelve patients underwent
additional procedures at the time of the Ch-EVAR proce-
dure. Thirty-six of 37 (97.3%) planned branch vessels were
able to be successfully chimney stented. One renal artery
was inadvertently occluded from loss of guidewire access.
Renal artery stents were between 5 and 8 mm in diameter
and 20 to 59 mm in length. SMA stents were 7 or 8 mm in
diameter and 38 or 59 mm in length. The mean number of
chimney stents used was 2.1  0.4 per patient.
Thirty-day and in-hospital mortality was 4.8% with one
Fig 4. Patient selection process of endovascular chimn
Computed tomographic angiograms; HD, hemodialysis;
Table I. Patient demographic and anatomical data
n
Age (years, mean  SD)
Male (n, %)
Comorbidities (median, range)
Comorbidities (n, %)
CAD
MI
Arrhythmia
HTN
COPD
O2-dependent
CRI
Creatinine (mg/dL, mean  SD)
eGFR (mL/min/1.73 m2, mean  SD)
Aneurysm size (mm, mean  SD)
Infrarenal LZ length (mm, median, range)
Chimney LZ length (mm, median, range)
Neck length gained (mm, median, range)
Neck diameter for Ch-EVAR (mm, mean  SD)
Infrarenal neck angulation (degrees, mean  SD)
CAD, Coronary artery disease; Ch-EVAR, endovascular chimney repair; C
eGFR, estimated glomerular filtration rate; HTN, hypertension; LZ, landingdeath in each group (Table III). There was one intraoper- ative death in the open group from a proximal anastomotic
leed. There was one death in the Ch-EVAR group on
ostoperative day 11 prior to discharge from a myocardial
nfarction. Blood loss, transfusion requirements, intensive
are, and total hospital LOS were all significantly less for
h-EVAR. Tables IV and V list the complications that
ccurred in each group. The total number of complications
29 vs 60) was less for Ch-EVARwith nearly one-half being
ccess-related or AKI. The median number of complica-
ions in each group was one. There were two minor strokes
n the Ch-EVAR group and a trend toward a higher inci-
ence of pulmonary complications (10% vs 29% patients, P
.13) in the OR group. The number of patients dis-
harged home was similar in each group (Ch-EVAR 14
70%] vs OR 12 [60%], P .74). The two late deaths in the
pen group were on postoperative days 218 and 456. The
wo late deaths in the Ch-EVAR group were on postoper-
air (Ch-EVAR) and open repair (OR) patients. CTAs,
, superior mesenteric artery.
h-EVAR OR P
21 21 1.0
2  8 73  6 .70
(52) 16 (76) .11
(1-7) 2 (1-5) .12
(52) 11 (52) 1.0
(29) 5 (24) .73
(24) 4 (19) .71
(86) 19 (90) .64
(67) 9 (43) .13
(29) 1 (5) .04
(19) 0 (0) .04
.2  0.5 1.0  0.3 .08
1  35 73  17 .06
.8  12.7 60.5  9.9 .09
(0-11) 3 (0-40) .49
(17-42) 21.5 (17-41) .83
(8-35) 19 (11-36) .84
.1  5.1 26.7  4 .79
9  22 24  13 .32
chronic obstructive pulmonary disease; CRI, chronic renal insufficiency;
; MI, myocardial infarction; O2, oxygen.ey repC
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Volume 53, Number 4 Bruen et al 899Renal function. Six (29%) patients in the Ch-EVAR
group with one intentionally covered renal artery had AKI.
There was one patient preoperatively on hemodialysis in
whom both renal arteries were intentionally occluded and a
single SMA chimney stent was placed. This subject was
excluded from renal function analysis. In the OR group,
one patient met criteria for AKI and four had ARF. One of
these four patients required temporary hemodialysis and
two required chronic hemodialysis. Clamp placements in
these four patients were supraceliac in one, supramesenteric
in one, and suprarenal in two. Midterm evaluation of renal
function showed similar declines in the overall eGFR in
both groups (11.1  19.6 vs 10.4  25.2 mL/min/
1.73 m2, P  .66). Subgroup analysis of the Ch-EVAR
Table II. Indications, device characteristics, and
adjunctive procedures
Indication n
AAA 14
Type I endoleak, s/p prior EVAR 2
Anastomotic pseudoaneurysm 4
Symptomatic atheromatous disease 1
Proximal aortic stent graft
Zenith flexa 12
Zenith Renua 3
TX2a 2
TX2/aTalent thoracicb 1
Zenith flex/aTalent thoracicb 1
Zenith flex/aTX2a 1
Excluderc 1
Adjunctive procedures
TEVAR 3
Iliac conduit/iliofemoral bypass 3
Femoral-femoral bypass 2
Femoral patch/interposition graft 3
Hypogastric coiling 2
Hypogastric bypass 1
SMA stent 1
Renal artery coiling 1
Brachial artery repair 1
Thrombectomy 1
Chimney stents (technical success) 36/37 (97%)
(97%)
Renal artery chimney
Bilateral 8
Right 4
Left 8
SMA chimney 9
Types of chimney stent 44
Covered balloon expandable (iCast)d 29
Uncovered self-expanding nitinol (Zilver)a 10
Uncovered balloon expandable (formula 418)a 3
Covered self-expanding (Viabahn)c 2
Stents/patient (mean  SD) 2.1  0.7
No. of stents/vessel, mean  SD 1.2  0.4
AAA, Abdominal aortic aneurysm;Ch-EVAR, endovascular chimney repair;
EVAR, endovascular aneurysm repair; OR, open repair; SMA, superior
mesenteric artery; TEVAR, thoracic endovascular aortic repair.
aCook Inc, Indianapolis, Ind.
bMedtronic, Minneapolis, Minn.
cW. L. Gore, Flagstaff, Ariz.
dAtrium Medical Corporation, Hudson, Mass.group showed that those patients with intentional coverage af one renal artery (ie, SMA  1 renal) contributed to the
ajority of the overall decline in renal function of the
ohort (25.7 22.5 vs2.0 11.1 mL/min/1.73 m2,
 .13). Average contrast load was 188 mL (range 120-
80 mL) and did not correlate with decline in renal func-
ion. Those patients in whom both renal arteries were able
o be maintained had preservation of their baseline renal
unction. In those renal arteries that were successfully chim-
ey stented, no infarcts were detected on the postoperative
TA.
Late survival. Kaplan-Meier estimates of survival at 12
onths were nearly identical for both groups at 89.1% and
7.3% (Fig 5). There were two late deaths in each group. In
he Ch-EVAR group, one died of a myocardial infarction and
ne from congestive heart failure. In the OR group, one died
f recurrent pneumonia and a second from an unknown
ause.
Chimney stent patency and endoleak. There was
ne asymptomatic SMA stent occlusion on the 6-month
TA. A second SMA stent was found to be partially com-
ressed on the 6-month follow-up CTA. This was able to
e completely re-expanded with repeat balloon angio-
lasty. There were no cases of renal stent occlusion. Primary
atency at 6 and 12 months was 94% and 84%, respectively
Fig 6).
Endoleak was evaluated by CTA or with color-flow
uplex ultrasound in patients with renal insufficiency.
here was a single type Ia endoleak in a single renal
himney repair noted on the 1-month CTA, which resolved
pontaneously, and subsequently showed a type II en-
oleak on the 6-month CTA. This patient’s clopidogrel
as discontinued after 1 month due to minor bleeding
rom a gastric ulcer. She was eventually restarted on aspirin
t 6-month follow-up. The aneurysm sac size remained
nchanged.
There were two other type II endoleaks, one that
esolved in a patient with a single renal chimney, and
nother in a patient with a double renal chimney that was
resent on the 1-month CTA. All of the type II endoleaks
ere from lumbar branches. There were no type III en-
oleaks. Aneurysm size change (5 mm) decreased in five
29%), was the same in 11 (65%), and increased in one (6%).
he one patient with an increase in aneurysm size had a
ype II endoleak that resolved.
Implantable device costs for Ch-EVAR. Implantable
evices in Ch-EVAR consisted of the endograft compo-
ents and the chimney stents. Using list prices provided by
he respective manufacturers, the mean cost of only the
mplantable devices was US$18,833 (range, US$8125-
32,624). The endograft pieces comprised a mean of 74%
f the total implantable device cost of the procedure.
ISCUSSION
A number of case series have used the chimney tech-
ique to preserve visceral branch perfusion in EVAR26,27,29
nd to preserve arch branch perfusion during thoracic
ndovascular aortic repair (TEVAR).24,25,28 Ready avail-
bility of conventional endograft components and periph-
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urgent symptomatic and emergent ruptured aneurysms as
an “off-the-shelf” solution.26 Current pure endovascu-
Table III. Perioperative outcomes
Outcome Ch-E
30-day mortality 1 (4.
Procedure time (min, median, range) 235 (13
EBL (mL, median, range) 350 (10
PRBC transfusion (units, median, range) 1 (0-
ICU LOS (days, median, range) 1 (0-
Total LOS (days, median, range) 5 (1-
Complications
Total 2
Median (range) 1 (0-
Ch-EVAR, Endovascular chimney repair; EBL, estimated blood loss; ICU, inte
Table IV. Operative characteristics and complications of O
Patient
Proximal clamp
level (above
vessel)
Highest
anastomosis
level Aortic graft
1 SMA SMA Tube
2 SMA Right renal Aortoiliac
3 Celiac Celiac Tube
4 Infrarenal Renal Aortoiliac
5 Infrarenal Renal Tube
6 Renal Renal Tube
7 Celiac SMA Tube
8 Celiac SMA Tube
9 Infrarenal Renal Tube
10 Celiac Celiac Tube
11 Renal Renal Tube
12 Renal Renal Aortoiliac
13 Infrarenal Renal Aortofemoral
14 Renal Renal Aortoiliac
15 Renal Renal Tube
16 Renal Renal Tube
17 Renal Renal Tube
18 Renal Renal Tube
19 Renal Renal Tube
20 Celiac Renal Aortoiliac
21 Celiac Celiac Tube
ARF, Acute renal failure; DVT, deep vein thrombosis; GIB, gastrointesti
infarction; OR, open repair; SMA, superior mesenteric artery; UTI, urinary
aDefined as serum creatinine rise 30% from baseline resulting in a persistelar approaches include fenestrated9 and branched en- tografts,17 which are not widely available and require 6 to
weeks to be custom manufactured.
The chimney technique fundamentally differs from
OR P
1 (4.8%) 1.0
5) 213 (147-782) 0.65
00) 1500 (250-30,000) .001
3 (0-48) .007
4 (1-166) .001
10 (4-166) .021
60
1 (0-20) .989
are unit; LOS, length of stay; OR, open repair; PRBC, packed red blood cells.
roup
Additional
procedures Complications
None
Arrhythmia, ionotropic support, ventilation
24 hours, pleural effusion, pulmonary
edema, pneumonia, reintubation,
tracheostomy, increased creatinine,a ARF
requiring HD, permanent HD, ileus 4
days, GIB (2), bowel resection,
Clostridium difficile colitis, DVT, wound
requiring debridement, UTI
renal Cardiac arrest, arrhythmia, ionotropic
support, femoral thrombosis,
embolization, reoperation for
anastomotic leak, ventilation 24 hours,
reintubation, pneumonia, increased
creatinine,a ARF requiring HD,
permanent HD, GIB, bowel resection,
wound breakdown
Pulmonary edema
Pneumonia, ileus 4 days, UTI
Ileus 4 days
renal Wound breakdown
Ventilation 24 hours, reintubation,
tracheostomy, pneumonia
None
SMA,
torenal
Intraoperative bleeding, MI, death
ARF requiring HD, ileus 4 days
reimplantation None
Ileus 4 days
None
UTI
None
renal Increased creatinine,a UTI
None
None
renal None
l reimplantation Arrhythmia, pneumonia
eed; HD, hemodialysis; IMA, inferior mesenteric artery; MI, myocardial
nfection.
e 2.0 mg/dL.VAR
8%)
6-48
0-10
11)
11)
18)
9
8)R g
None
None
Aorto
None
None
None
Aorto
None
None
Aorto
aor
None
IMA
None
None
None
None
Aorto
None
None
Aorto
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Volume 53, Number 4 Bruen et al 901visceral stents to the aortic stent graft. While fenestrated
and branched visceral stents are mated and sealed within
integral constructs of the endograft, chimney stents are
positioned along the outside of the endografts, and relies
on the close conformation of the endograft and the aortic
wall around the chimney stent (Fig 7).
The therapeutic efficacy and safety of any of these
endovascular approaches must be compared against con-
ventional open repair, which remains the “gold standard”.
Single-center experiences have reported excellent 30-day
mortality rates between 1.8% and 5.8%.20,34,35 Major mor-
bidities including myocardial infarction, renal insufficiency,
hemodialysis, stroke, and pneumonia ranged from 10% to
22%. In a multivariate analysis, Beck identified age 70,
COPD, creatinine 1.8 mg/dL, and a suprarenal cross
clamp as independent risk factors of mortality at 1 year.21
Using a predictive model, 1-year mortality for open repair
ranged from 8% to 22% if two risk factors were present, 22%
Table V. Visceral stent configuration and perioperative
complications of Ch-EVAR group
Patient
Ch-EVAR
Configuration Complications
1 Single renal Ileus 4 days
2 Double renal Access site pseudoaneurysm,
ileus 4 days, increased
creatininea
3 Double renal None
4 Double renal Increased creatinine,a
pulmonary edema
5 Single renal None
6 Double renal Renal artery occlusion,b
increased creatinine,a
pulmonary edema
7 SMA/single renal Increased creatininea
8 Single renal None
9 SMA/single renal Access site pseudoaneurysm
(2)
10 SMA/single renal Stroke, MI, reintubation,
tracheostomy,
pneumonia, increased
creatinine,a bowel
ischemia, death
11 Double renal None
12 SMA/single renal Arterial thrombosis, vascular
injury
13 Single renal None
14 SMA/single renal Ileus 4 days
15 SMA None
16 SMA/single renal Arterial thrombosis
17 SMA/single renal Arterial thrombosis
18 SMA/single renal Increased creatininea
19 Double renal None
20 Double renal Stroke, vascular injury, UTI
21 Double renal None
ARF, Acute renal failure; Ch-EVAR, endovascular chimney repair; MI,
myocardial infarction; SMA, superior mesenteric artery; UTI, urinary tract
infection.
aDefined as serum creatinine rise 30% from baseline resulting in a persis-
tent value 2.0 mg/dL.
bLost guidewire access.to 38% for three factors, and up to 67% for all four factors. ty comparison for EVAR, aneurysm size 6.5 cm and
ongestive heart failure were associated with a 1-year mor-
ality of 8% and 11%, respectively, which increased to 24% if
oth were present.21
Recently, published fenestrated endograft studies have
hown promising results. In a French multicenter trial
nvolving 134 patients, the 30-day mortality rate was 2%
nd the target vessel patency rate on completion angiogra-
hy was 99%.10 The incidence of transient and permanent
emodialysis in the series was 3% and 1%, respectively.
erhoeven et al reported on an 8-year single center expe-
ience of 100 patients who underwent fenestrated EVAR.
hirty-day mortality was 1%, and visceral vessel patency was
3.3% at 5 years.11
The decision to cover one of the renal arteries in cases
hat required an SMA stent was based on our assumption
hat two chimney stents were probably the maximum num-
er that could be used without compromising the proximal
eal. To our knowledge, this has never been systematically
tudied or reported. Despite the apparently counterintui-
Fig 5. Kaplan-Meier estimate of survival.
ig 6. Kaplan-Meier estimate of primary patency of chimney
tents.ive nature of the chimney technique with its undermining
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the early and late follow-up has been small.26,27 Hiramoto
reported a series of single renal artery chimney stent EVAR
in eight patients.27 Although two of the patients initially
demonstrated a type I endoleak on the immediate postop-
erative CTA, both of these resolved on 1-month imaging.
None of the chimney stents developed stenosis or occlusion
on follow-up. In the current series there was only one type
I endoleak which resolved by 6 months.
The mechanism of a seal around the chimney stents by
closure of the so-called “gutters” around the chimney stent
is likely multifactorial. The interactions of the graft material
and the particular stent architecture of an endograft may
determine the degree of conformation of the endograft
around the chimney stent. Examination of cross-sectional
imaging suggests local deformation of the native aortic wall
itself by the chimney stent (Fig 7). One can speculate
therefore that localized rigidity of the aortic wall, as might
occur in transmural calcifications, might be a risk factor for
an endoleak. Beyond the physical closure of the “gutter”,
the length of the “new” proximal neck traversed by the
endograft and the chimney stent also likely contributes to
the seal. Resistance to flow is proportional to the length of
the flow channel. Therefore, the longer the length of the
gutter, the greater the chance for spontaneous thrombosis
of the flow channel. The minimum length of the gutter
required to cause early thrombosis has never been studied
and this itself is likely dependent on a host of mechanical
factors. Finally, the presence of a minimum sealing “ring”
or segment below the chimney stent, such as in a funnel-
shaped neck, may be a desirable but not a necessary condi-
tion. If such a sealing segment were present, use of an
Fig 7. Localized deformation of the aortic wall and close confor-
mation around the chimney stents.uncovered bare stent may be adequate. Uncovered self- sxpanding stents were selected early in our experience
ecause of their flexibility and lower profile. However, in
he absence of such a seal zone, a covered stent intuitively
eems superior from seal standpoint and also provides
reater radial force. Furthermore, fenestrated and branched
ndograft experience suggests improved patency over bare
tents.36 Finally, while some have advocated use of Palmaz
tents and additional oversizing of the aortic endograft
eyond the manufacturer’s guidelines, we have not per-
ormed either of these methods as their utility has not been
learly established.27
Renal insufficiency after open repair of juxtarenal and
uprarenal aneurysms has been reported to be between 8%
nd 28%, with incidence of hemodialysis ranging from 0.6%
o 5.8%.19,20,34,35 In the current study, the incidence of
enal injury or failure and hemodialysis in the OR group
as 24% and 14%, respectively, with two (9.5%) patients
equiring chronic hemodialysis. Renal function following
enestrated endograft repairs has been associated with sim-
lar rates of decline (defined as serum creatinine30% over
aseline) ranging between 4% and 23%, with a 5.5% inci-
ence of renal failure requiring hemodialysis.8
The stability of the chimney-stented segment of the
roximal aortic neck and the late patency of stents remain
elatively poorly defined and close follow-up is required.
urrent schedule of follow-up of these patients is more
ntense than for standard EVAR and involve 6-month
maging studies and serum creatinine levels. In the event of
himney stent stenosis, repeat angioplasty or placement of
n additional stent may be necessary. Although this has not
een required to date, persistent or late occurrence of a type
endoleak may be treated with proximal endograft exten-
ion with placement of a chimney stent in a more superior
essel, direct coil and/or glue embolization of the gut-
ers,37 or open surgical conversion. However, considering
hese patients were high risk for open repair initially, no
urther intervention may be most appropriate.
The chimney technique presently fills an unmet need in
ases where more advanced endograft technologies are not
vailable. However, even if fenestrated devices were avail-
ble, as they require a minimum of 4mm of infrarenal neck,
nly 5 (23.8%) patients in the current series would have
een potential candidates. Production time of these custom
evices is also an issue. Although not reported, anecdotally
here are numerous cases of interval rupture of aneurysms
rom the time of evaluation and availability of the devices.
ff-the-shelf branched devices that could be used to fit a
ajority of anatomies are in early stages of develop-
ent.38,39 Finally, the role of the chimney technique in the
ontext of other off-label techniques such as “back-table”
nd in situ fenestrations remains unknown.40 At the current
ime, chimney techniques are best viewed as complemen-
ary (vs competing) techniques in the continuing effort to
vercome the morbidity of open repair of these aneurysms
n a consistent and widespreadmanner outside of a few high
olume centers of expertise.
The economics of these therapies should also be con-
idered. Although the granularity of published data does
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costs of these different endovascular approaches, chimney
stenting may offer a cost advantage over fenestrated or
branched technologies. Considering the most frequently
utilized Ch-EVAR configuration was an aortic bifurcated
graft with balloon expandable covered stents, device list
pricing would suggest a cost of $16,879 for a 1-vessel repair
and $19,554 for a 2-vessel repair. By comparison, the cost
of a fenestrated repair utilizing balloon expandable covered
stents is $21,675 for a 1-vessel and $24,350 for a 2- or
3-vessel repair (with an SMA scallop). A branched device
utilizing balloon expandable covered and reinforcing un-
covered stents is approximately $38,716 for a 2-vessel and
$42,574 for a 3-vessel repair. To give perspective to these
numbers, the cost of a knitted graft for open repair is
$582.00. These costs obviously do not address the late
durability of these repairs and the need for any secondary
procedures that will contribute to the overall cost of the
therapy.
The ideal candidate and procedural steps for Ch-EVAR
remain to be defined. From our initial experience, tech-
nique appears to be suited for patients at high risk for open
repair and symptomatic or contained ruptured aneurysms.
Patients with severe atheromatous arch disease are likely at
greater risk for neurologic complications during this pro-
cedure. This must be weighed against the operative risk
associated with open repair. The decision to intentionally
cover a renal artery mandates extensive discussion with
patient and family about the risks and potential benefits.
Anatomically, patients should have down-going renal arter-
ies and a minimum of 20 mm of disease-free proximal seal
zone. Open surgical exposure of the brachial/axillary artery
is recommended. We had two cases of late SMA stent
occlusion/compression, which may be related to the mo-
tion of the vessel occurring during the respiratory cycle.
Despite the operator’s decision to perform a balloon angio-
plasty in one of the cases, we would advocate placing a
second stent in the future. An additional reinforcing stent
within the SMA at the time of the initial procedure may also
reduce the risk of compression.
Endovascular repair of juxtarenal and suprarenal aortic
aneurysms remains an evolving area in vascular surgery. The
current study showed that Ch-EVAR is technically feasible
with successful exclusion of the aneurysm and can be per-
formed with low morbidity and mortality in a cohort of
patients deemed unfit for open repair. It is a complemen-
tary approach to fenestrated and branched devices with a
distinct advantage of being able to be performed with
readily available components. Long-term durability, in-
cluding preservation of graft fixation, seal, and branch
vessel patency remain to be determined.
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Dr Matthew Eagleton (Cleveland, Ohio). When we design
our fenestrated and branched endografts, one of the things that we
take into account is the renal artery morphology. We have to take
this into account when determining where to place the fenestra-
tions. We end up approaching upward-going and downward-
going renal arteries differently. It appears, based on your descrip-
tion of the snorkel technique, that the procedure is really geared
towards only patients with downward-going renal arteries. Do you
have anatomic selection criteria for these patients, and do you
exclude patients based on renal artery morphology, or have you
lost renal arteries because they take a trajectory 180 degrees from
the direction of the stent?
Dr Bruen. We do consider the angle of takeoff of the renal
arteries preoperatively. Clearly, the preferred configuration is in a
down-going renal artery. We have used on occasion a combination
of a covered self-expanding stent for the angled portion of the
artery and a covered balloon-expandable stent near the top of the
aortic stent.
Dr Timothy Kresowik (Iowa City, Iowa). I have some ques-
tions about your endovascular technique. What is your approach
with respect to access, ie, upper extremity, lower extremity, or
both? What is the order of the aortic vs visceral/renal stents/stent
grafts?
Dr Bruen. Access to the visceral and renal arteries is obtained
from upper extremities. Depending on how many vessels need to
be chimney stented or the caliber of the brachial artery, sheaths are
introduced through an axillary cut down and occasionally via an
axillary conduit.m interested in your choice of stent. Are you using balloon-
xpandable covered stents? self-expanding stents? And are you
djusting the size of your aortic endograft? Are you using more
enerous oversizing to perhaps compensate for the extra room
hat you are using?
Dr Bruen. We have preferentially used covered balloon-
xpandable stents. And your second question?
Dr Sternbergh. The criteria for oversizing of your aortic
ndograft, are you changing that at all? Are you increasing your
versizing to accommodate for the extra room that you are perhaps
sing?
Dr Bruen.No, we are not. We use the manufacturer’s recom-
ended oversizing.
Dr Mark Fillinger (Lebanon, NH). I would like to compli-
ent you first for a nice analysis using a comparison to open
ontrols with similar anatomy. That is a nice type of analysis for a
eport regarding new technology. My comment is about the
nalysis of seal zone. Because inevitably there is a gutter when you
ave a chimney stent graft, no matter how you hope that the aorta
ill mold around the chimney. There is some controversy about
his, but my opinion is that you need at least 5 mm below the
owest chimney to consistently get a seal. I was wondering how you
nalyze your seal zone preoperatively based on that, and whether
ou have analyzed your results postoperatively in that regard?
Dr Bruen. We use a minimum neck length of 20 mm, 5 mm
onger than the instructions for use (IFU) for infrarenal report, to
eal the gutter.
Dr Fillinger. So do you look for a seal zone below the lowest
himney device? Do you look for 5 mm there or do you ignore
hat?
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lowest chimney device.
Dr Roy Greenberg (Cleveland, Ohio). I have some concerns.
I presented this technique in 2002 at the SVS and at that time I
thought it was a great technique. However, when we looked at our
patients, we found that a significant number of patients who did
have a sealing zone below the renals, albeit short one, and under-
went a chimney technique, required many supplementary stents,
including balloon-expandable stent inside self-expanding stents all
within a renal, in addition to a Palmaz stent in the aorta. Yet when
we looked at our patients after treatment, they had a higher
incidence of endoleaks, less aneurysm shrinkage, andmore growth.
Whenever you find yourself adding a lot of devices into a very small
region, from an engineering perspective, it spells late disaster. And
if such patients develop a problem later on, you have kind of
pinned yourself into a corner. Given that these patients have shortave a higher risk of failure of endovascular treatment, and bemore
ifficult to salvage without open surgery, which hopefully they
annot tolerate well before the first procedure, otherwise you
hould operate on them open.
In that context, perhaps you can clarity for us exactly what
ou are doing to create the chimneys to obtain a seal, as well as
ny adjunctive stenting within the neck. Were these covered
tents or uncovered stents, balloon-expandable, self-expanding?
id you have to supplement the seals with a Palmaz stent
roximally? Have you seen any major problems? Do you have a
trategy about how to handle issues should they come up in the
uture?
Dr Bruen. I think patient selection is everything. The stents
hat we used initially were self-expanding stents. We are now using
alloon-expandable covered stents. We do not use Palmaz stents
roximally. But patients have to have adequate anatomy or they donecks, I would bet their likelihood of disease progression (aortic
degeneration) is also higher. Thus, this patient population will
not get repaired. If this technique fails in the late term, probably,
the only option is surgical conversion.
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